C-reactive protein levels in schizophrenia: a review and meta-analysis [0.03%]
精神分裂症患者C-反应蛋白水平的meta分析及综述
Brian J Miller,Nick Culpepper,Mark H Rapaport
Brian J Miller
There is an impression in the literature that schizophrenia is associated with increased inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein (CRP). We performed a meta-analysis of blood CRP levels to...
Religion's effect on mental health in schizophrenia: examining the roles of meaning-making and seeking social support [0.03%]
宗教对精神分裂症患者心理健康的影响：探讨赋义和寻求社会支持的作用
Naomi T Tabak,Amy Weisman de Mamani
Naomi T Tabak
While a growing body of research suggests that religion offers mental health benefits for individuals with schizophrenia, few studies have examined the mechanisms underlying this effect. The present study investigated two potential mediator...
Nash N Boutros,Armida Mucci,Vaibhav Diwadkar et al.
Nash N Boutros et al.
Clinical heterogeneity is a confound common to all of schizophrenia research. Deficit schizophrenia has been proposed as a homogeneous disease entity within the schizophrenia syndrome. Utilizing the Schedule for the Deficit Syndrome (SDS) h...
Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease [0.03%]
精神分裂症和特发性帕金森病共病的临床特点
Maarten H de Jong,Désirée Zemel,Arthur R Van Gool
Maarten H de Jong
The comorbidity of schizophrenia and idiopathic Parkinson's disease (IPD) is illustrated by a case description of a schizophrenic patient who develops motor symptoms finally diagnosed and treated as comorbid IPD. Several aspects of the clin...
Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease [0.03%]
利培酮缓释片治疗肝病伴发的精神分裂症或分裂情感障碍患者的疗效及安全性研究
Joan Amatniek,Carla M Canuso,Stephen I Deutsch et al.
Joan Amatniek et al.
Background/purpose: Patients with schizophrenia often suffer from comorbid hepatic disease. This multicenter, open-label, single-arm, crossover study evaluated the safety and efficacy of paliperidone extended-release (ER)...
Multicenter Study
Clinical schizophrenia & related psychoses. 2014 Apr;8(1):8-20. DOI:10.3371/CSRP.AMCA.021513 2014
Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients [0.03%]
关于首发与多发精神分裂症患者服药依从性影响因素的对照研究
Mamta Sapra,Peter J Weiden,Nina R Schooler et al.
Mamta Sapra et al.
Rationale: Most first-episode schizophrenia patients will stop their medication after their acute symptoms improve. Understanding the salient motivations and attitudes that drive adherence--as well as nonadherence--is an ...
Mind-body medicine for schizophrenia and psychotic disorders: a review of the evidence [0.03%]
精神医学在分裂症和精神病发作性疾病中的应用：证据回顾
Chanel Helgason,Jerome Sarris
Chanel Helgason
Over half of psychiatric patients use some kind of Complementary and Alternative Medicine, with Mind-Body Medicine (MBM) being the most commonly used collective modality. To date however, to our knowledge, no overarching review exists exami...
Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine [0.03%]
奥氮平长效注射剂或口服制剂治疗精神分裂症患者后的锥体外系症状发生率
Angela L Hill,Bin Sun,David P McDonnell
Angela L Hill
Background: The incidence of extrapyramidal symptoms (EPS) has been shown to be generally low among patients with schizophrenia receiving oral olanzapine. A long-acting injection (LAI) of olanzapine has recently been appr...
John Kasckow,Kandi Felmet,Cathleen Appelt et al.
John Kasckow et al.
Background: Telehealth technology has become more available to providers as a means of treating chronic diseases. Consideration of the applicability of telehealth technology in the treatment of schizophrenia calls for a r...
Rapid resolution of psychotic symptoms in a patient with schizophrenia using allopurinol as an adjuvant: a case report [0.03%]
阿洛普尿作为辅助疗法快速缓解一名精神分裂症患者的幻觉和妄想症状的病例报告
Noah Linden,Angela Onwuanibe,Neil Sandson
Noah Linden
Context: Despite multiple trials of different adjuvant therapies to an antipsychotic regimen, there have been few promising results. Allopurinol may be one promising adjunctive therapy based on three randomized controlled...